Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Farmacia Hospitalaria
versión On-line ISSN 2171-8695versión impresa ISSN 1130-6343
Resumen
CASAJUS-NAVASAL, Andrea et al. Prevalence of the consumption of anticholinergic drugs in HIV patients. Farm Hosp. [online]. 2018, vol.42, n.1, pp.1-4. ISSN 2171-8695. https://dx.doi.org/10.7399/fh.10842.
Objective:
To analyse anticholinergic agent consumption in HIV patients 50 years or older; to determine anticholinergic risk using the Anticholinergic Cognitive Burden Scale (ACB) and Anticholinergic Risk Scale (ARS); and to determine if these patients use any type of benzodiazepine.
Method:
A descriptive observational study of 256 HIV patients 50 years or older.
Results:
73.1% were men. Mean age was 56 ± 5.9 years. 55.9% of the patients were coinfected with HCV. Excluding HIV drugs, mean drug consumption was 2.9 ± 2.9 drugs per patient. The ACB and ARS scales showed that 26.2% and 17.2% of the patients took an anticholinergic agent, and that 43.3% and 36.4% presented high anticholinergic risk, respectively. 30.5% of patients consumed benzodiazepines.
Conclusions:
The percentage of HIV patients aged 50 years or older who were taking anticholinergic agents was statistically significantly higher on the ACB scale than on the ARS scale. No studies are available on the HIV population with which to compare our results, but there is evidence that this group of drugs can affect older adults.
Palabras clave : HIV; Elderly; Anticholinergic Cognitive Burden Scale (ACB); Anticholinergic Risk Scale (ARS); Benzodiazepine.